ISAD and ISPD marked World Atopic Eczema Day on September 14 by urging equitable, affordable access to the …
Phase 2b results show rezpegaldesleukin significantly improved eczema severity, itch and quality of life in adults with moderate-to-severe …
New noninvasive biomarker models can objectively assess atopic dermatitis severity and detect hidden inflammation even in skin that …
The International Society of Atopic Dermatitis has funded the MEDIATE Initiative, a project developing an AI-powered digital agent …
NICE is evaluating lebrikizumab for treating moderate-to-severe atopic dermatitis in children and young people, assessing its clinical and …
Sanofi ends development of amlitelimab for atopic dermatitis after concluding that available efficacy and safety data do not …
ISAD Vice-President Dr Roberto Takaoka visited Manaus to help launch a new patient support group and highlight the …